针对SHP2:结直肠癌治疗中的双重突破 - - 从信号通路调制到免疫微环境重塑

Pan Liu1, Jia Chen2

  • 1Department of Pathology, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, China.

概括

向SHP2 (一种氨酸酸酶) 提供了通过调节瘤生长信号和重编程瘤微环境来治疗结直肠癌 (CRC) 的双重策略. 在CRC治疗的临床试验中,SHP2抑制剂正在取得进展.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K